Effect of Hydrocortisone on Development of Shock Among Patients With Severe SepsisDidier Keh, Stefan P. Wirtz, Emad Abduljawwad et al.|JAMA|2016Cited by 265
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre‐François Laterre, Anne-Aurore Duchambon, Peter Pickkers et al.|Intensive Care Medicine|2021Cited by 92